Combined, these findings demonstrate that depending on the signaling context RANK activation can give rise to malignancies originating from different B-cell subsets and provides a rationale to further explore possible tumor-promoting roles of RANKL expressing cells in the tumor-microenvironment of MM. The gene discussed is TNFRSF11A; the disease is Miyoshi myopathy.